583P Baseline plasma tumour DNA (ptDNA) correlates with PSA kinetics in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide. - Conteduca, V.; Scarpi, E.; Wetterskog, D.; Brighi, N.; Schepisi, G.; Romanel, A.; Casadei, C.; Lolli, C.; Gurioli, G.; Toma, I.; Poti, G.; Farolfi, A.; et al. (Annals of Oncology, 2021)